AMEX · MYO
Myomo, Inc.
Healthcare · Medical - Devices
$1.24▼ 4.62% ($0.06)at close
After hours$1.23▼ 0.81%7:01 PM ET
Market cap
$49.11M
P/E
N/M
EPS (TTM)
-$0.34
Valuation
Revenue & margin DCF
A cash-flow estimate wouldn't be reliable here
9 of 10 projected years produce negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.
- 10-yr revenue CAGR
- 16.6%
- Ending operating margin
- 0.0%
- Discount rate
- 12.0%
USD · TTM ending Jun 30, 2026 · Price used $1.24 · Price Oct 30, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 33.33% over the last year. Revenue grew 6.14% over the trailing twelve months. Operating margin moved from -22.85% to -27.05%. Free cash flow grew 30.87% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 24th percentile of their historical P/S range.
What would invalidate this read
Operating margin is at -27.05%. Revenue grew 6.14% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Return analysis
Company profile
Myomo, Inc. is a medical technology company specializing in wearable robotics.
Market multiples
Stock splits
Every 30 shares became 1
Profitability & growth
Analyst consensus
7
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 9, 2026
Q3 FY26 · EPS est -$0.08 · Revenue est $11.5M
Q2 FY26
Reported Aug 5, 2026 · Latest
HoverTap a quarter to inspect
Actual
-$0.07
Estimate
-$0.10
Year over year
n/m
Vs prior quarter
n/m
4 beats in the last 4 quarters
Institutional Sentiment
Myomo, Inc. · MYO
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.